inHEART, SAS

Company profile

About inHEART, SAS

inHEART is a medical device company delivering the world's most advanced, AI-enabled digital twin of the heart to transform the treatment of cardiac arrhythmias. The company's proprietary segmentation algorithms analyze CT and MRI images to create sophisticated, cloud-based 3D cardiac models with unprecedented anatomical detail of tissue and structural characteristics. These digital twins provide cardiac electrophysiologists with detailed pre-procedural insights into each patient's unique cardiac anatomy, including cardiac structures, collateral anatomy, and myocardial tissue characteristics such as scar tissue, fatty infiltrate, and wall thinning. The platform seamlessly integrates with all major electroanatomic mapping (EAM) systems including Carto, Rhythmia, Ensite, and Affera for use during procedures. inHEART's solution has demonstrated significant clinical impact, with studies showing a 60% reduction in procedure times and 38% reduction in ventricular tachycardia recurrence rates compared to conventional approaches. The company serves over 300 partner hospitals across 40+ countries and has supported more than 7,500 cases. With headquarters in France and a US office in Cambridge, Massachusetts, inHEART is committed to providing all patients access to world-class cardiac imaging expertise to optimize treatment strategies, improve clinical outcomes, and return patients to full, healthy lives.

Company description · inHEART, SAS official website